Blocknomi
TLDR IBRX climbs 1.12% to $9.91 as FDA expands ANKTIVA’s bladder cancer approval. FDA clears ANKTIVA plus BCG for papillary-only bladder cancer patients in the U.S. ANKTIVA’s wider label opens…
Related articles
-
Bitcoin speculators move 55K BTC to exchanges amid $1.1B liquidations
Cointelegraph Published 09.10.2026 09:50
-
Bitcoin Price Prediction: BTC Reclaims $82K as Oil Retreats and Bulls Return
Cryptonews Published 19.10.2026 07:34
-
Blur to shut down frontend next month as NFT trading volume dwindles
The Block Published 12.10.2026 21:49
-
UEFA Champions League Prediction Odds: Barcelona Leads at 22.5%
Cryptonews Published 08.10.2026 09:33
-
NEAR Protocol Weighs Issuance Cut as Staking Rewards Face Drop
Blocknomi Published 02.10.2026 08:32
-
Solana Hits 14M Stablecoin Holders as Card Volume Tops $1B
Bitcoin.com Published 07.10.2026 15:40
-
2,213% Liquidation Imbalance Crushes XRP Bulls Amid Market-Wide Selloff
U.Today Published 07.10.2026 10:48
-
Elon Musk Grok AI Predicts a Wild End to 2026 for Bitcoin
Cryptonews Published 03.10.2026 14:00